EUVIMEDEUVIMED entdecken
Crossref

Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation

Marzieh Izadifard iD, Mohammad Ahmadvand iD, Hossein Pashaiefar iD, Kamran Alimoghadam iD, Amir Kasaeian iD, Maryam Barkhordar iD, Ghazal Seghatoleslami iD, Mohammad Vaezi iD, Ardeshir Ghavamzadeh iD, Marjan Yaghmaie iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Marzieh Izadifard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, …. Hauptthemen laut MEDLINE: Graft vs Host Disease, MicroRNAs, Hematopoietic Stem Cell Transplantation, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are currently no laboratory tests that can accurately predict the likelihood of developing acute graft‐versus‐host disease (aGVHD), a patient's response to treatment, or their survival chance. This research aimed to establish circulating miRNAs as diagnostic, prognostic, or predictive biomarkers of aGVHD.

Methods

In a prospective cohort, we studied the incidence of cutaneous aGVHD in AML patients undergoing allo‐HSCT at Shariati Hospital in Tehran, Iran during 2020–2023. Patients with cutaneous aGVHD were labeled as the case group, while patients without cutaneous aGVHD were selected as the control group. Accordingly, the expression levels of six significant miRNAs (miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, miR‐548a‐3p) were evaluated by quantitative reverse transcription–polymerase chain reaction (RTqPCR) in three different time‐points: before transplantation, on day 14 and day 21 after transplantation.

Results

The levels of plasma miR‐455‐3p, miR‐5787, miR‐638, and miR‐3613‐5p were significantly downregulated, while miR‐548a‐3p, and miR‐6511b‐5p were significantly upregulated in individuals with cutaneous aGVHD in comparison to patients without GVHD. Additionally, the possibility for great diagnostic accuracy for cutaneous aGVHD was revealed by ROC curve analysis of differentially expressed miRNAs (DEMs).

Conclusion

The study findings encourage us to hypothesize that the aforementioned miRNAs may contribute to the predominance of aGVHD, particularly low‐grade cutaneous aGVHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseMicroRNAsHematopoietic Stem Cell TransplantationBiomarkersHumansMaleFemaleProspective StudiesAdultPrognosisMiddle AgedFollow-Up StudiesTransplantation, HomologousCase-Control StudiesYoung AdultAdolescentSkin DiseasesLeukemia, Myeloid, Acute

Stichwörter der Autor:innen

acute myeloid leukemiacirculating miRNAscutaneous aGVHDdiagnostichematopoietic stem cell transplantationnon‐invasive biomarkers

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

ORCID-Profile: Marzieh Izadifard, Mohammad Ahmadvand, Hossein Pashaiefar, Kamran Alimoghadam, Amir Kasaeian, Maryam Barkhordar, Ghazal Seghatoleslami, Mohammad Vaezi, Ardeshir Ghavamzadeh, Marjan Yaghmaie

Förderung

  • Tehran University of Medical Sciences, Tehran, Iran, and Student Research Committee
  • Tehran University of Medical Sciences, Tehran, Iran

Zitieren

APA

Izadifard, M., Ahmadvand, M., Pashaiefar, H., Alimoghadam, K., Kasaeian, A., Barkhordar, M., Seghatoleslami, G., Vaezi, M., Ghavamzadeh, A., & Yaghmaie, M. (2024). Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15371

Vancouver

Izadifard M, Ahmadvand M, Pashaiefar H, Alimoghadam K, Kasaeian A, Barkhordar M, et al. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15371

BibTeX
@article{Izadifard2024,
  author = {Izadifard, Marzieh and Ahmadvand, Mohammad and Pashaiefar, Hossein and Alimoghadam, Kamran and Kasaeian, Amir and Barkhordar, Maryam and Seghatoleslami, Ghazal and Vaezi, Mohammad and Ghavamzadeh, Ardeshir and Yaghmaie, Marjan},
  title = {Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15371}
}
Kostenlos starten →